These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18312300)

  • 21. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.
    Gordon JL; Girdler SS; Meltzer-Brody SE; Stika CS; Thurston RC; Clark CT; Prairie BA; Moses-Kolko E; Joffe H; Wisner KL
    Am J Psychiatry; 2015 Mar; 172(3):227-36. PubMed ID: 25585035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders.
    Bravo JA; Dinan TG; Cryan JF
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):666-83. PubMed ID: 20860876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cerebello-hypothalamic-pituitary-adrenal axis dysregulation hypothesis in depressive disorder.
    Schutter DJ
    Med Hypotheses; 2012 Dec; 79(6):779-83. PubMed ID: 22999737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and psychosocial correlates of head and neck cancer: a review of the literature.
    De Boer MF; McCormick LK; Pruyn JF; Ryckman RM; van den Borne BW
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):427-36. PubMed ID: 10064650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressive Symptoms, Systemic Inflammation, and Survival Among Patients With Head and Neck Cancer.
    Cash E; Albert C; Palmer I; Polzin B; Kabithe A; Crawford D; Bumpous JM; Sephton SE
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):405-413. PubMed ID: 38546616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a normal HPA axis response to psychosocial stress in patients remitted from depression.
    Lange C; Zschucke E; Ising M; Uhr M; Bermpohl F; Adli M
    Psychoneuroendocrinology; 2013 Nov; 38(11):2729-36. PubMed ID: 23931983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms.
    Howren MB; Christensen AJ; Karnell LH; Funk GF
    Health Psychol; 2010 Jan; 29(1):65-71. PubMed ID: 20063937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Depression and type 2 diabetes: etiopathogenic analysis of a frequent comorbidity].
    Luppens D; Piette C; Radermecker RP; Scantamburlo G; Ansseau M; Pitchot W
    Rev Med Liege; 2014 Nov; 69(11):611-7. PubMed ID: 25796774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders.
    Ehlert U; Nater UM; Böhmelt A
    J Psychosom Res; 2005 Jul; 59(1):7-10. PubMed ID: 16126090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Post-traumatic stress, post-traumatic depression and major depressive episode: literature].
    Ducrocq F; Vaiva G; Cottencin O; Molenda S; Bailly D
    Encephale; 2001; 27(2):159-68. PubMed ID: 11407268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates.
    Weiss EL; Longhurst JG; Mazure CM
    Am J Psychiatry; 1999 Jun; 156(6):816-28. PubMed ID: 10360118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head and Neck Cancer: Identifying Depression as a Comorbidity Among Patients.
    Friedland CJ
    Clin J Oncol Nurs; 2019 Feb; 23(1):99-102. PubMed ID: 30681992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis, and inflammation/immunity.
    Huang TL; Chen JF
    Adv Clin Chem; 2005; 39():81-105. PubMed ID: 16013668
    [No Abstract]   [Full Text] [Related]  

  • 35. Depressive disorder as possible risk factor of osteoporosis.
    Vrkljan M; Thaller V; Lovricević I; Gaćina P; Resetić J; Bekić M; Sonicki Z
    Coll Antropol; 2001 Dec; 25(2):485-92. PubMed ID: 11811278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial.
    Lazure KE; Lydiatt WM; Denman D; Burke WJ
    Head Neck; 2009 Jul; 31(7):888-92. PubMed ID: 19309726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V; Dinan TG; Scott L; Corcoran C
    Biol Psychiatry; 2005 Dec; 58(12):963-8. PubMed ID: 16005439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support.
    de Leeuw JR; de Graeff A; Ros WJ; Blijham GH; Hordijk GJ; Winnubst JA
    Head Neck; 2000 Dec; 22(8):799-807. PubMed ID: 11084641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal actions of glucocorticoids: focus on depression.
    Yu S; Holsboer F; Almeida OF
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):300-9. PubMed ID: 17933520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.